documents: FDA-2008-N-0039-0027
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2008-N-0039-0027 | FDA | FDA-2008-N-0039 | FOI Summary for Zilpaterol, NADA 141-284m ZILMAX plus MGA (Zipaterol Hydrochloride and Melengestrol Acetatate) Type A Medicated Articles | Supporting & Related Material | Freedom of Information Summary | 2008-04-02T04:00:00Z | 2008 | 4 | 2013-07-10T17:16:49Z | 0 | 0 | 090000648041496e |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref